NIKKEI 225
27,821.76 -462.16 (-1.63%) HANG SENG
23,475.26 -376.98 (-1.58%) CRUDE OIL
65.16 -4.79 (-6.85%) GOLD FUTURES
1,776.40 -8.80 (-0.49%) DOW
34,496.16 -639.78 (-1.82%) BTC-GBP
43,339.30 -1,154.39 (-2.59%)
Bayer Aktiengesellschaft (BAYN.DE)
| Previous close | 45.32 |
| Open | 45.00 |
| Bid | 44.79 x 28400 |
| Ask | 44.83 x 2100 |
| Day's range | 44.22 - 45.12 |
| 52-week range | 44.22 - 57.73 |
| Volume | |
| Avg. volume | 2,593,082 |
| Market cap | 43.738B |
| Beta (5Y monthly) | 1.33 |
| PE ratio (TTM) | 296.80 |
| EPS (TTM) | 0.15 |
| Earnings date | 09 Nov 2021 |
| Forward dividend & yield | 2.00 (4.39%) |
| Ex-dividend date | 28 Apr 2021 |
| 1y target est | N/A |
- Reuters
Breaking up is not for us, Bayer CEO says
German drugs and pesticides maker Bayer has no plans to split its three main businesses into separately traded companies, Chief Executive Werner Baumann said, amid a flurry of conglomerates moving to break themselves up. "We are going to continue the course, which is developing our company along the three pillars that we have - pharmaceuticals, crop science and consumer health," Baumann told Bloomberg in an interview published on Thursday. The comments come after conglomerates such as Johnson & Johnson, Toshiba and General Electric announced plans this month to split up, aiming to simplify their structures and increase focus.
- Bloomberg
Microsoft and Bayer Team Up to Make Digital Tools for Agriculture
(Bloomberg) -- Bayer AG and Microsoft Corp. are collaborating on new internet-based products aimed at helping farmers and industries tied to agriculture become more efficient and sustainable.Most Read from BloombergStartup Fever Is Gripping the World’s Last Big Untapped NationWhat Designers of Video Game Cities Understand About Real CitiesElizabeth Holmes Faces Last-Ditch Chance to Testify at TrialChronically Underfunded HBCUs Eye Scholarships in Biden BillBayer is partnering with the U.S. softw
- Zacks
Pharma Stock Roundup: AZN, BAYRY Q3 Results, PFE COVID Pill's Strong Efficacy
AstraZeneca (AZN) and Bayer (BAYRY) announce Q3 results. Pfizer's (PFE) COVID-19 pill reduces hospitalizations and deaths substantially.
